Concepts (64)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Hemofiltration | 3 | 2017 | 14 | 1.540 |
Why?
|
| Brain Injuries | 3 | 2017 | 76 | 1.430 |
Why?
|
| Renal Replacement Therapy | 3 | 2017 | 17 | 1.140 |
Why?
|
| Vasospasm, Intracranial | 1 | 2021 | 15 | 0.720 |
Why?
|
| Brain Ischemia | 2 | 2021 | 262 | 0.710 |
Why?
|
| Subarachnoid Hemorrhage | 1 | 2021 | 42 | 0.700 |
Why?
|
| Encephalocele | 1 | 2015 | 12 | 0.470 |
Why?
|
| Brain Edema | 1 | 2015 | 15 | 0.470 |
Why?
|
| Embolism, Paradoxical | 1 | 2015 | 5 | 0.470 |
Why?
|
| Thrombophilia | 1 | 2015 | 10 | 0.470 |
Why?
|
| Foramen Ovale, Patent | 1 | 2015 | 6 | 0.470 |
Why?
|
| Decision Making | 1 | 2017 | 272 | 0.460 |
Why?
|
| Venous Thrombosis | 1 | 2015 | 65 | 0.440 |
Why?
|
| Acute Kidney Injury | 1 | 2015 | 63 | 0.440 |
Why?
|
| Stroke | 1 | 2015 | 731 | 0.290 |
Why?
|
| Oncogene Proteins | 2 | 2013 | 28 | 0.180 |
Why?
|
| Brain Injuries, Traumatic | 1 | 2022 | 74 | 0.180 |
Why?
|
| Intensive Care Units | 1 | 2022 | 215 | 0.170 |
Why?
|
| Hedgehog Proteins | 2 | 2013 | 97 | 0.170 |
Why?
|
| Bed Rest | 1 | 2019 | 8 | 0.160 |
Why?
|
| Middle Aged | 4 | 2019 | 10090 | 0.160 |
Why?
|
| Trans-Activators | 2 | 2013 | 277 | 0.150 |
Why?
|
| Thrombolytic Therapy | 1 | 2019 | 129 | 0.150 |
Why?
|
| Humans | 7 | 2022 | 40217 | 0.150 |
Why?
|
| Zebrafish | 2 | 2013 | 301 | 0.140 |
Why?
|
| Adolescent | 2 | 2017 | 4034 | 0.140 |
Why?
|
| Renal Dialysis | 1 | 2017 | 124 | 0.130 |
Why?
|
| Aged | 3 | 2019 | 8182 | 0.120 |
Why?
|
| Male | 4 | 2019 | 18271 | 0.120 |
Why?
|
| Inflammation | 1 | 2021 | 912 | 0.120 |
Why?
|
| Adult | 3 | 2022 | 10255 | 0.120 |
Why?
|
| Fatal Outcome | 1 | 2015 | 69 | 0.120 |
Why?
|
| Female | 4 | 2019 | 20392 | 0.110 |
Why?
|
| Heat-Shock Response | 1 | 2013 | 28 | 0.100 |
Why?
|
| Prevalence | 1 | 2015 | 870 | 0.100 |
Why?
|
| Zebrafish Proteins | 2 | 2013 | 143 | 0.090 |
Why?
|
| Retrospective Studies | 2 | 2019 | 3138 | 0.090 |
Why?
|
| Young Adult | 1 | 2017 | 2877 | 0.080 |
Why?
|
| Endocrine Cells | 1 | 2008 | 10 | 0.080 |
Why?
|
| Pituitary Gland | 1 | 2008 | 47 | 0.070 |
Why?
|
| Risk Factors | 1 | 2015 | 3141 | 0.070 |
Why?
|
| Cohort Studies | 2 | 2022 | 1479 | 0.070 |
Why?
|
| Glasgow Coma Scale | 1 | 2022 | 19 | 0.050 |
Why?
|
| Zinc Finger Protein GLI1 | 2 | 2013 | 28 | 0.040 |
Why?
|
| Embryo, Nonmammalian | 2 | 2013 | 164 | 0.040 |
Why?
|
| Hospital Mortality | 1 | 2022 | 459 | 0.040 |
Why?
|
| Prognosis | 1 | 2022 | 921 | 0.040 |
Why?
|
| Time Factors | 1 | 2019 | 2422 | 0.030 |
Why?
|
| Treatment Outcome | 1 | 2019 | 2863 | 0.020 |
Why?
|
| Aged, 80 and over | 1 | 2019 | 3136 | 0.020 |
Why?
|
| HSP70 Heat-Shock Proteins | 1 | 2013 | 71 | 0.020 |
Why?
|
| Animals, Genetically Modified | 1 | 2013 | 266 | 0.020 |
Why?
|
| Signal Transduction | 2 | 2013 | 2581 | 0.020 |
Why?
|
| Green Fluorescent Proteins | 1 | 2013 | 336 | 0.020 |
Why?
|
| Promoter Regions, Genetic | 1 | 2013 | 578 | 0.020 |
Why?
|
| Gene Expression Regulation, Developmental | 1 | 2013 | 569 | 0.020 |
Why?
|
| Veratrum Alkaloids | 1 | 2008 | 8 | 0.020 |
Why?
|
| Zinc Finger Protein Gli2 | 1 | 2008 | 24 | 0.020 |
Why?
|
| Pituitary Gland, Anterior | 1 | 2008 | 29 | 0.020 |
Why?
|
| Body Patterning | 1 | 2008 | 78 | 0.020 |
Why?
|
| Animals | 2 | 2013 | 16893 | 0.010 |
Why?
|
| Cell Differentiation | 1 | 2008 | 1116 | 0.010 |
Why?
|
| Mutation | 1 | 2008 | 2123 | 0.010 |
Why?
|
| Transcription Factors | 1 | 2008 | 1328 | 0.010 |
Why?
|